Evidence map›Paper›PMID 25669433›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2015

Proliferation of Multiple Cell Types in the Skeletal Muscle Tissue Elicited by Acute p21 Suppression.

Maria Grazia Biferi, Carmine Nicoletti, Germana Falcone, Eleonora M R Puggioni, Nunzia Passaro, Alessia Mazzola, Deborah Pajalunga, Germana Zaccagnini, Emanuele Rizzuto, Alberto Auricchio and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Maria Grazia BiferiDepartment of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy.
Carmine NicolettiInstitute Pasteur Cenci-Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, IIM, Sapienza University of Rome, Rome, Italy.
Germana FalconeDepartment of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy; Institute of Cell Biology and Neurobiology, National Research Council, Monterotondo, Italy.
Eleonora M R PuggioniDepartment of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy.
Nunzia PassaroDepartment of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy.
Alessia MazzolaDepartment of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy.
Deborah PajalungaDepartment of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy.
Germana ZaccagniniMolecular Cardiology Laboratory, IRCCS-Policlinico San Donato, Milan, Italy.
Emanuele RizzutoDepartment of Mechanical and Aerospace Engineering, IIM, Sapienza University of Rome, Rome, Italy.
Alberto AuricchioDivision of Medical Genetics, Department of Translational Medicine, "Federico II" University, Naples, Italy; Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
Lorena ZentilinMolecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Gabriele De LucaDepartment of Ematology, Oncology and Molecular Medicine, National Institute of Health, Rome, Italy.
Mauro GiaccaMolecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Fabio MartelliMolecular Cardiology Laboratory, IRCCS-Policlinico San Donato, Milan, Italy.
Antonio MusioInstitute of Biomedical and Genetic Research, National Research Council, Pisa, Italy; Tumour Institute of Tuscany, Florence, Italy.
Antonio MusaròInstitute Pasteur Cenci-Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, IIM, Sapienza University of Rome, Rome, Italy; Center for Life Nano Science@Sapienza, Italian Institute of Technology, Genova, Italy.
Marco CrescenziDepartment of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy. Electronic address: marco.crescenzi@iss.it.
Istituto Superiore di Sanità · ITInternational Centre for Genetic Engineering and Biotechnology · ITIRCCS Policlinico San Donato · ITSapienza University of Rome · ITFederico II University Hospital · ITInstitute of Cell Biology and Neurobiology · ITIstituto Pasteur · ITNational Research Council · IT

Funding

European Research Council 250124Telethon GGP13013Telethon GGP14092
6 · The paper itself

Abstract

Although in the last decades the molecular underpinnings of the cell cycle have been unraveled, the acquired knowledge has been rarely translated into practical applications. Here, we investigate the feasibility and safety of triggering proliferation in vivo by temporary suppression of the cyclin-dependent kinase inhibitor, p21. Adeno-associated virus (AAV)-mediated, acute knockdown of p21 in intact skeletal muscles elicited proliferation of multiple, otherwise quiescent cell types, notably including satellite cells. Compared with controls, p21-suppressed muscles exhibited a striking two- to threefold expansion in cellularity and increased fiber numbers by 10 days post-transduction, with no detectable inflammation. These changes partially persisted for at least 60 days, indicating that the muscles had undergone lasting modifications. Furthermore, morphological hyperplasia was accompanied by 20% increases in maximum strength and resistance to fatigue. To assess the safety of transiently suppressing p21, cells subjected to p21 knockdown in vitro were analyzed for γ-H2AX accumulation, DNA fragmentation, cytogenetic abnormalities, ploidy, and mutations. Moreover, the differentiation competence of p21-suppressed myoblasts was investigated. These assays confirmed that transient suppression of p21 causes no genetic damage and does not impair differentiation. Our results establish the basis for further exploring the manipulation of the cell cycle as a strategy in regenerative medicine.

Indexed as

AnimalsCell CycleCell DifferentiationCell ProliferationChromosome AberrationsCyclin-Dependent Kinase Inhibitor p21DependovirusFibroblastsGene ExpressionGene Knockdown TechniquesGenes, ReporterGenetic VectorsHumansImmunohistochemistryMiceMuscle ContractionCyclin-Dependent Kinase Inhibitor p21RNA, Small Interfering

Identifiers

PMID25669433
PMCPMC4424006
OpenAlexW2313471157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.